Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabetes Researchers Say FDA Is Slowing Artificial Pancreas Efforts

This article was originally published in The Pink Sheet Daily

Executive Summary

The U.S. is "desperately behind the curve," as a "result of regulatory policy that is just not working in the interest of people who live with type 1 diabetes," JDRF CEO says.

You may also be interested in...



With 16 IDEs Approved, FDA Still Questions Artificial Pancreas Study Designs

Since 2003, FDA has approved 16 investigational device exemptions for companies to begin trials on "artificial pancreas" devices, yet the agency is questioning what constitutes an appropriate study design for the products.

Diabetes Foundation, Device Firms Partner To Develop Artificial Pancreas

The Juvenile Diabetes Research Foundation has begun partnering with device companies to speed the commercialization of artificial pancreas technology that would take some of the guesswork out of diabetes management

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel